Blood urea nitrogen to serum albumin ratio as a new prognostic indicator in type 2 diabetes mellitus patients with chronic kidney disease

Shizhen Liu,Chuangye Qiu,Wenxia Li,Xingai Li,Fanna Liu,Guoqiang Hu
DOI: https://doi.org/10.1038/s41598-024-58678-4
IF: 4.6
2024-04-07
Scientific Reports
Abstract:Chronic kidney disease (CKD) is often a common comorbidity in critically ill patients with type 2 diabetes mellitus (T2DM). This study explored the relationship between blood urea nitrogen to serum albumin ratio (BAR) and mortality in T2DM patients with CKD in intensive care unit (ICU). Patients were recruited from the Medical Information Mart database, retrospectively. The primary and secondary outcomes were 90-day mortality, the length of ICU stay, hospital mortality and 30-day mortality, respectively. Cox regression model and Kaplan–Meier survival curve were performed to explore the association between BAR and 90-day mortality. Subgroup analyses were performed to determine the consistency of this association. A total of 1920 patients were enrolled and divided into the three groups (BAR 21.3). The length of ICU stay, 30-day mortality, and 90-day mortality in the BAR > 21.3 group were significantly higher than other groups. In Cox regression analysis showed that high BAR level was significantly associated with increased greater risk of 90-day mortality. The adjusted HR (95%CIs) for the model 1, model 2, and model 3 were 1.768 (1.409–2.218), 1.934, (1.489–2.511), and 1.864, (1.399–2.487), respectively. Subgroup analysis also showed the consistency of results. The Kaplan–Meier survival curve analysis revealed similar results as well that BAR > 21.3 had lower 90-day survival rate. High BAR was significantly associated with increased risk of 90-day mortality. BAR could be a simple and useful prognostic tool in T2DM patients with CKD in ICU.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the relationship between the blood urea nitrogen to serum albumin ratio (BAR) and the prognosis of type 2 diabetes mellitus (T2DM) patients with chronic kidney disease (CKD) in the intensive care unit (ICU), especially the relationship with the 90 - day mortality rate. The study aims to evaluate whether BAR can be an independent predictor of 90 - day mortality in T2DM patients with CKD in the ICU and explore its potential application value in clinical practice. ### Research Background - **Global prevalence of diabetes and chronic kidney disease**: According to the prediction of the International Diabetes Federation, the number of global diabetes patients will reach 454 million by 2030 and will further increase to 783 million by 2045. Type 2 diabetes (T2DM) and chronic kidney disease (CKD) are both chronic diseases, and the proportion of T2DM patients with CKD is relatively high, approximately 64 - 81.6/10,000. - **The impact of T2DM combined with CKD**: T2DM combined with CKD will significantly reduce the patient's life expectancy, increase the medical cost burden and mortality rate. These patients need to restrict their diet during daily treatment and are prone to malnutrition, thus affecting the prognosis before admission. - **The role of blood urea nitrogen (BUN) and serum albumin (ALB)**: - **BUN**: It not only reflects the state of renal function, but also is related to the level of protein metabolism and inflammation. High BUN levels are positively correlated with adverse renal outcomes. - **ALB**: It is the main component of plasma proteins, and slight changes will affect the patient's prognosis. Low ALB levels accelerate the decline of renal function. - **The clinical significance of BAR**: Previous studies have shown that BAR can be a useful biomarker for adverse prognoses in many diseases, such as gastrointestinal bleeding, sepsis, COVID - 19 and acute kidney injury. ### Research Objectives - **Evaluate the relationship between BAR and the prognosis of T2DM patients with CKD in the ICU**: Through a retrospective cohort study, using the data in the MIMIC - III database, analyze the relationship between BAR and the 90 - day mortality rate. - **Determine the reliability and independence of BAR as a prognostic indicator**: Through Cox regression analysis and Kaplan - Meier survival curves, evaluate the independent role of BAR in predicting the 90 - day mortality rate. ### Main Findings - **High BAR levels are significantly associated with 90 - day mortality**: Multivariate Cox regression analysis showed that high BAR levels (> 21.3) were significantly associated with a significant increase in 90 - day mortality, and the adjusted HRs were 1.768 (1.409 - 2.218), 1.934 (1.489 - 2.511) and 1.864 (1.399 - 2.487) respectively. - **Kaplan - Meier survival curve analysis**: The 90 - day survival rate in the high BAR group (> 21.3) was significantly lower than that in other groups. - **Subgroup analysis**: In different subgroups, high BAR levels were still significantly associated with 90 - day mortality, such as age > 75 years, male, hypertension, heart failure, coronary artery disease, SOFA score ≥ 5, etc. ### Conclusions - **High BAR levels are significantly associated with 90 - day mortality**: BAR can be an independent predictor of 90 - day mortality in T2DM patients with CKD in the ICU, which is simple and easy to obtain, and is helpful for clinical decision - making and patient management. ### Limitations - **Single - center retrospective study**: There may be selection bias. - **Old data**: The data recording time was from 2001 to 2002. - **Some clinical information is missing**: Information not recorded in the database may affect the results. - **The impact of dynamically changing BAR is unclear**: Only the BUN and ALB records at the patient's first admission are included. - **The mechanism is unknown**: The specific mechanism by which BAR affects the prognosis has not been determined. ### Future Directions - **Multi - center prospective study**: Further verify the above results and explore the mechanism by which BAR affects the prognosis.